SEC Form 4 · accession 0000930413-19-000102
ENZO BIOCHEM INC · ENZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Barry W Weiner
Officer — Pres, CFO Prin Acct Ofcr Treas · Director
Period of report
Jan 14, 2019
Accepted (ET)
Jan 18, 2019 · 4:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000316253
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jan 14, 2019 | M | 2,226 | $2.70 | A | 1,136,918 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (to acquire common stock)F1 | $2.70 | Jan 14, 2019 | M | 33,305 | D | — | Jan 17, 2019 | Common Stock | 33,305 | 151,489 | D |
Explanation of responses
- F1Represents an exercise of options to acquire 33,305 shares, which, after the company withheld the exercise price for such options and the applicable taxes, resulted in a delivery of 2,226 shares to the reporting person.
- F2Includes (i) 3,638 shares that Mr. Weiner holds as custodian for certain of his children, and of which Mr. Weiner disclaims beneficial ownership and (ii) 33,557 shares held in the company's 401(k) plan.